EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 23-Jun-2026 08:16 ET (23-Jun-2026 12:16 GMT/UTC)

25-Mar-2026

Scientists call out health-harming corporations driving rise in chronic disease

University of Sydney
Peer-Reviewed Publication

Chronic diseases including cancer, diabetes, neurocognitive disorders and infertility are rising globally, with health-harming products such as fossil fuels, tobacco, ultra‑processed foods, toxic chemicals, plastics and alcohol being major contributors, say the authors of a new paper published in New England Journal of Medicine (NEJM). The authors include proposed solutions, including policy safeguards and a stronger research focus on the risks to health connected with corporate activity.

Journal: New England Journal of Medicine

25-Mar-2026

Registration for TCT 2026 now open

Cardiovascular Research Foundation
Meeting Announcement

The Cardiovascular Research Foundation® (CRF®) is pleased to announce registration is open for TCT® 2026 (Transcatheter Cardiovascular Therapeutics®), the world’s premier educational symposium in interventional cardiovascular medicine. TCT 2026 will take place October 31 – November 3, at the San Diego Convention Center in San Diego, California.

Meeting: TCT 2026: Transcatheter Cardiovascular Therapeutics

25-Mar-2026

First Chagas disease conference on US soil highlights a turning point in national awareness

Tulane University
Meeting Announcement

For the first time ever, a conference dedicated to Chagas disease research will be held on U.S. soil, marking a significant and symbolic moment for researchers, clinicians and public health leaders working to boost awareness of the disease in this country. It comes at a pivotal time, as researchers argue in favor of Chagas disease being considered endemic in the United States.

25-Mar-2026

UT Health San Antonio launches clinical trial to study rapamycin and healthy aging

The University of Texas at San Antonio Health Science Center
Business Announcement

UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase clinical study to better understand how the drug rapamycin may promote healthy aging. Funded by the National Institute on Aging, the study will examine dosing, safety and long-term effects to help guide future research on extending health span.

25-Mar-2026

Surgical management and reconstruction strategies highlighted for head and neck basal cell carcinoma

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — March 26, 2026 — A new research perspective was published in Volume 13 of Oncoscienceon March 11, 2026, titled “Basal cell carcinoma of the head and neck: Surgical management and postoperative strategies – A researcher’s perspective.”

Journal: Oncoscience

25-Mar-2026

Ependymoma fusion protein locks cells in developmental limbo

St. Jude Children's Research Hospital
Peer-Reviewed Publication

St. Jude Children’s Research Hospital and Baylor College of Medicine scientists show how ZFTA-RELA fusions hijack developmental programs to drive a type of pediatric brain cancer.

Journal: Nature

25-Mar-2026

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder

Monash University
Peer-Reviewed Publication

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto natural fat absorption pathways to allow oral delivery of some drugs previously requiring injection.

Journal: Science Translational Medicine

25-Mar-2026

Largest clinical trial using brain training to reduce dementia receives $2.8 million in federal funding for USF

University of South Florida
Grant and Award Announcement

An expansive clinical trial led by University of South Florida researchers and aimed at delaying the onset of dementia continues to receive major federal support with an additional $2.8 million from the National Institutes of Health. The funding helps to continue research into whether computerized brain training exercises can reduce the risk of cognitive impairment and dementia such as Alzheimer’s disease. The Preventing Alzheimer’s with Cognitive Training (PACT) study has now received more than $50 million in federal grant funding.

25-Mar-2026

Douglas P. Kiel, MD, MPH, elected to the Association of American Physicians

Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research
Business Announcement

Douglas P. Kiel, MD, MPH, a senior scientist and director of the Musculoskeletal Research Center at the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, has been elected to membership in the Association of American Physicians, one of the nation’s most prestigious honorary medical societies. He is a professor of medicine at Harvard Medical School.